{"name": "Theravance",
 "permalink": "theravance",
 "crunchbase_url": "http://www.crunchbase.com/company/theravance",
 "homepage_url": "http://www.theravance.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "investor.relations@theravance.com",
 "phone_number": "650-808-6000",
 "description": "",
 "created_at": "Tue Nov 30 04:04:15 UTC 2010",
 "updated_at": "Tue Nov 30 04:05:05 UTC 2010",
 "overview": "\u003Cp\u003ETheravance, Inc. (Theravance) is a biopharmaceutical company with a pipeline of internally discovered product candidates. As of December 31, 2009, the Company is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas, including respiratory disease, bacterial infections and gastrointestinal motility dysfunction. Its programs include VIBATIV (telavancin) with Astellas Pharma Inc. (Astellas) and its RELOVAI program (formerly referred to as Horizon) and the Bifunctional Muscarinic Antagonist-beta2 Agonist (MABA) program with GlaxoSmithKline plc (GSK).\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       60],
      "assets/images/resized/0011/2217/112217v1-max-150x150.png"],
     [[152,
       61],
      "assets/images/resized/0011/2217/112217v1-max-250x250.png"],
     [[152,
       61],
      "assets/images/resized/0011/2217/112217v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman and CEO",
    "person":
     {"first_name": "Rick",
      "last_name": "E Winningham",
      "permalink": "rick-e-winningham",
      "image": null}},
   {"is_past": false,
    "title": "Senior Vice President and CFO",
    "person":
     {"first_name": "Michael",
      "last_name": "W. Aguiar",
      "permalink": "michael-w-aguiar",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Robert",
      "last_name": "V. Gunderson, Jr",
      "permalink": "robert-v-gunderson-jr",
      "image": null}},
   {"is_past": true,
    "title": "Director and investor ",
    "person":
     {"first_name": "Wesley",
      "last_name": "D. Sterman",
      "permalink": "wesley-d-sterman",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$129M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://files.shareholder.com/downloads/THERA/1081492124x0x423203/75b3d5f1-c9fb-417f-8195-fcc7980964eb/GSK_to_Increase_Its_Shareholding_in_Theravance_Final_Press_Release_2010Nov29.pdf",
    "source_description": "GlaxoSmithKline to Increase Its Shareholding in Theravance",
    "raised_amount": 129375000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 11,
    "funded_day": 29,
    "investments":
     [{"company":
        {"name": "GlaxoSmithKline",
         "permalink": "glaxosmithkline",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0005/1020/51020v1-max-150x150.png"],
             [[158,
               54],
              "assets/images/resized/0005/1020/51020v1-max-250x250.png"],
             [[158,
               54],
              "assets/images/resized/0005/1020/51020v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "901 Gateway Blvd",
    "address2": "",
    "zip_code": "94080",
    "city": "South San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:THRX"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}